上海莼试生物技术有限公司
主营产品: ELISA试剂盒,ELISA试剂盒价格,ELISA试剂盒报价 |
联系电话
13585831301
公司信息
- 联系人:
- 李小姐
- 电话:
- 021-59541103
- 手机:
- 13585831301
- 售后电话:
- 13585831301
- 传真:
- 021-60443211
- 地址:
- 上海市嘉定区嘉罗公路1661号23号楼311
- 邮编:
参考价 | 面议 |
- 型号
- 品牌
- 厂商性质 经销商
- 所在地 上海市
更新时间:2017-07-23 18:46:17浏览次数:384
联系我们时请说明是环保在线上看到的信息,谢谢!
滑石粉14807-96-6说明书储存条件: 避光、干燥阴凉处封闭贮存,严禁与有毒、有害物品混放、混运。本品为非危险 产品可按一般化学品运输,轻搬动轻放,防止日晒、雨淋!受热、受潮、受光后易丧失活力,保存期短,因此贮存和运输条件比较苛刻。
产品名称 | 英文名称 | 价格 | |
Talc | 14807-96-6 | 电询 |
其他中文名称: 水合硅酸镁超细粉;一水硅酸镁;爽身粉
英文名称: Talc
其他英文名称: Hydrous magnesium silicate;Magnesium silicate hydrous;Magnesium silicate;Chalk french;French chalk
产品规格: BR,325目
包 装: 1公斤
:14807-96-6
3MgO·4SiO2·H2O=379.27
级别:BR
含量:≥98%
目数:325目(45μm)
白度:≥90.0%
水份:≤0.5%
铁盐:不即时显蓝色
水中可溶物:≤0.1%
酸中可溶物:≤1.5%
灼烧失量(800℃):≤5.0%
酸碱性:石蕊试纸呈中性反应
性状:、乳或浅灰色、有珍珠或脂肪光泽的片状或鳞片状粉末。不溶于水,不溶于冷酸和碱
用途:生化研究。广泛应用于油漆、油墨、涂料、塑料、橡胶、陶瓷、玻璃、电子等领域
保存:RT
特点:
1,全:公司提供上万种产品,涵盖了生物试剂,elisa试剂盒,标准品,培养基,原装耗材等,基本上各种科研所需产品在我司都能找到。
2,新:产品更新速度较快,基本上每周都有新产品出现。
3,优:产品质量好,*。
4,品牌多:公司代理sigma,amresco,oxoid,wako,R&D,RB,MBL,TCI,GIBIO,等国内外
5.售后:我公司具有优质的技术团队,产品一旦售出,实验过程中遇到困难可提供在线技术咨询。使您使用产品时没有任何的后顾之忧。
主要优级纯、分级纯和化学纯3种:
(1)优级纯(GR:Guaranteed reagent),又称一级品或保证试剂,99.8%,这种试剂纯度zui高,杂质含量zui低,适合于重要精密的分析工作和科学研究工作,使用绿色瓶签。
(2)分析纯(AR),又称二级试剂,纯度很高,99.7%,略次于优级纯,适合于重要分析及一般研究工作,使用红色瓶签。
(3)化学纯(CP),又称三级试剂,≥ 99.5%,纯度与分析纯相差较大,适用于工矿、学校一般分析工作。使用蓝色(深蓝色)标签。
(4)实验试剂(LR:Laboratory reagent),又称四级试剂。
公司提供的*,货源充足。严格的质量控制体系,包括:优级纯,分析纯,化学纯,试剂级,基准试剂,实验纯,教学试剂,高纯试剂,色谱纯,光谱纯,电子纯。各种包装规格,并可提供包装定制,咨询订购。
姜酮;Zingerone 122-48-5 20mg 订购|咨询
甲基莲心碱;Neferine 2292-16-2 20mg 订购|咨询
N-甲基野靛碱;Caulophyllin 486-86-2 20mg 订购|咨询
肌醇; Inositol 87-89-8 20mg 订购|咨询
加兰他敏;Galanthamine 357-70-0 20mg 订购|咨询
甲基;Methyl hesperi 11013-97-1 20mg 订购|咨询
京尼平;Genipin 6902-77-8 20mg 订购|咨询
酒石酸伐仑克林;Varenicline 375815-87-5 20mg 订购|咨询
甲基黄连碱;Worenine chlor 20mg 订购|咨询
吉马酮;Germacrone 6902-91-6 20mg 订购|咨询
剑麻皂苷元;Tigogenin 77-60-1 20mg 订购|咨询
金丝桃素;Hypericin 548-04-9 10mg 订购|咨询
桔皮素;Tangeretin 481-53-8 20mg 订购|咨询
2-金刚烷酮;2-Adamantanon 700-58-3 20mg 订购|咨询
8-姜酚;8-Gingerol 30462-35-2 20mg 订购|咨询
6-姜酚;6-Gingerol 23513-14-6 20mg 订购|咨询
2-金刚烷醇;2-Adamantanol 700-57-2 20mg 订购|咨询
金刚烷;Adamantane 281-23-2 20mg 订购|咨询
京尼平苷酸;Geniposidic ac 27741-01-1 20mg 订购|咨询
金石蚕苷;Poliumoside 94079-81-9 20mg 订购|咨询
G-36 (5 mg) (4S)-rel-4-(6-bromo-1,3-benzodioxol-5-yl)-3aR,4,5,9bS-tetrahydro-8-(1-methylethyl)-3H-cyclopenta[c]quinoline; G-36
G-36 (50 mg) (4S)-rel-4-(6-bromo-1,3-benzodioxol-5-yl)-3aR,4,5,9bS-tetrahydro-8-(1-methylethyl)-3H-cyclopenta[c]quinoline; G-36
MK 25 (hydrochloride) (10 mg) 5-(4-chlorophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide, monohydrochloride; MK 25 (hydrochloride)
MK 25 (hydrochloride) (25 mg) 5-(4-chlorophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide, monohydrochloride; MK 25 (hydrochloride)
MK 25 (hydrochloride) (5 mg) 5-(4-chlorophenyl)-N-[4-(1-piperazinyl)phenyl]-N-(2-pyridinylmethyl)-2-furancarboxamide, monohydrochloride; MK 25 (hydrochloride)
A-771726 (10 mg) 2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2Z-butenamide; Teriflunomide|Flucyamide|HMR 1726|SU 2A-771726
A-771726 (25 mg) 2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2Z-butenamide; Teriflunomide|Flucyamide|HMR 1726|SU 2A-771726
A-771726 (5 mg) 2-cyano-3-hydroxy-N-[4-(trifluoromethyl)phenyl]-2Z-butenamide; Teriflunomide|Flucyamide|HMR 1726|SU 2A-771726
β-Glycerophosphate (sodium salt hydrate) (100 g) 2-(dihydrogen phosphate)-1,2,3-propanetriol, disodium salt, pentahydrate; β-Glycerophosphate (sodium salt hydrate)
β-Glycerophosphate (sodium salt hydrate) (50 g) 2-(dihydrogen phosphate)-1,2,3-propanetriol, disodium salt, pentahydrate; β-Glycerophosphate (sodium salt hydrate)
5-(N-ethyl-N-isopropyl)-Amiloride (10 mg) 3-amino-N-(aminoiminomethyl)-6-chloro-5-[ethyl(1-methylethyl)amino]-2-pyrazinecarboxamide; EPIA|L-593,754|MH 12-43; 5-(N-ethyl-N-isopropyl)-Amiloride
5-(N-ethyl-N-isopropyl)-Amiloride (25 mg) 3-amino-N-(aminoiminomethyl)-6-chloro-5-[ethyl(1-methylethyl)amino]-2-pyrazinecarboxamide; EPIA|L-593,754|MH 12-43; 5-(N-ethyl-N-isopropyl)-Amiloride
5-(N-ethyl-N-isopropyl)-Amiloride (5 mg) 3-amino-N-(aminoiminomethyl)-6-chloro-5-[ethyl(1-methylethyl)amino]-2-pyrazinecarboxamide; EPIA|L-593,754|MH 12-43; 5-(N-ethyl-N-isopropyl)-Amiloride
SIRT1/2 Inhibitor IV (1 mg) 2,3-dihydro-5-[(2-hydroxy-1-naphthalenyl)methyl]-6-phenyl-2-thioxo-4(1H)-pyrimidinone; Cambinol|NSC 112546|SIRT1 Inhibitor II|SIRT2 Inhibitor VI; SIRT1/2 Inhibitor IV
SIRT1/2 Inhibitor IV (10 mg) 2,3-dihydro-5-[(2-hydroxy-1-naphthalenyl)methyl]-6-phenyl-2-thioxo-4(1H)-pyrimidinone; Cambinol|NSC 112546|SIRT1 Inhibitor II|SIRT2 Inhibitor VI; SIRT1/2 Inhibitor IV
SIRT1/2 Inhibitor IV (25 mg) 2,3-dihydro-5-[(2-hydroxy-1-naphthalenyl)methyl]-6-phenyl-2-thioxo-4(1H)-pyrimidinone; Cambinol|NSC 112546|SIRT1 Inhibitor II|SIRT2 Inhibitor VI; SIRT1/2 Inhibitor IV
SIRT1/2 Inhibitor IV (5 mg) 2,3-dihydro-5-[(2-hydroxy-1-naphthalenyl)methyl]-6-phenyl-2-thioxo-4(1H)-pyrimidinone; Cambinol|NSC 112546|SIRT1 Inhibitor II|SIRT2 Inhibitor VI; SIRT1/2 Inhibitor IV
Bucladesine (sodium salt) (100 mg) N-(1-oxobutyl)-cyclic 3’,5’-(hydrogen phosphate) 2’-butanoate-adenosine, monosodium salt; DC 2797; Bucladesine (sodium salt)
Bucladesine (sodium salt) (25 mg) N-(1-oxobutyl)-cyclic 3’,5’-(hydrogen phosphate) 2’-butanoate-adenosine, monosodium salt; DC 2797; Bucladesine (sodium salt)
Bucladesine (sodium salt) (250 mg) N-(1-oxobutyl)-cyclic 3’,5’-(hydrogen phosphate) 2’-butanoate-adenosine, monosodium salt; DC 2797; Bucladesine (sodium salt)
Bucladesine (sodium salt) (50 mg) N-(1-oxobutyl)-cyclic 3’,5’-(hydrogen phosphate) 2’-butanoate-adenosine, monosodium salt; DC 2797; Bucladesine (sodium salt)
Amiloride (hydrochloride) (1 g) 3,5-diamino-N-(aminoiminomethyl)-6-chloro-2-pyrazinecarboxamide, monohydrochloride; MK 87Amiloride (hydrochloride)
Amiloride (hydrochloride) (5 g) 3,5-diamino-N-(aminoiminomethyl)-6-chloro-2-pyrazinecarboxamide, monohydrochloride; MK 87Amiloride (hydrochloride)
(S)-3,5-DHPG (1 mg) (αS)-amino-3,5-dihydroxy-benzeneacetic acid; (S)-3,5-Dihydroxyphenylglycine; (S)-3,5-DHPG
(S)-3,5-DHPG (10 mg) (αS)-amino-3,5-dihydroxy-benzeneacetic acid; (S)-3,5-Dihydroxyphenylglycine; (S)-3,5-DHPG
(S)-3,5-DHPG (5 mg) (αS)-amino-3,5-dihydroxy-benzeneacetic acid; (S)-3,5-Dihydroxyphenylglycine; (S)-3,5-DHPG
Efavirenz (10 mg) (4S)-6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266|EFV|L-743,726; Efavirenz
Efavirenz (25 mg) (4S)-6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266|EFV|L-743,726; Efavirenz
Efavirenz (5 mg) (4S)-6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266|EFV|L-743,726; Efavirenz
Efavirenz (50 mg) (4S)-6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266|EFV|L-743,726; Efavirenz
HA-1100 (hydrochloride) (1 mg) 5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]-1(2H)-isoquinolinone, monohydrochloride; Hydroxyfasudil; HA-1100 (hydrochloride)
HA-1100 (hydrochloride) (10 mg) 5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]-1(2H)-isoquinolinone, monohydrochloride; Hydroxyfasudil; HA-1100 (hydrochloride)
HA-1100 (hydrochloride) (25 mg) 5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]-1(2H)-isoquinolinone, monohydrochloride; Hydroxyfasudil; HA-1100 (hydrochloride)
HA-1100 (hydrochloride) (5 mg) 5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]-1(2H)-isoquinolinone, monohydrochloride; Hydroxyfasudil; HA-1100 (hydrochloride)
Z-DEVD-FMK (1 mg) N-[(phenylmethoxy)carbonyl]-L-α-aspartyl-L-α-glutamyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]-L-valinamide, 1,2-dimethyl ester; Z-DEVD-FMK
Z-DEVD-FMK (5 mg) N-[(phenylmethoxy)carbonyl]-L-α-aspartyl-L-α-glutamyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]-L-valinamide, 1,2-dimethyl ester; Z-DEVD-FMK
Z-DEVD-FMK (500 ug) N-[(phenylmethoxy)carbonyl]-L-α-aspartyl-L-α-glutamyl-N-[(1S)-3-fluoro-1-(2-methoxy-2-oxoethyl)-2-oxopropyl]-L-valinamide, 1,2-dimethyl ester; Z-DEVD-FMK
LE 135 (1 mg) 4-(7,8,9,10-tetrahydro-5,7,7,10,10-pentamethyl-5H-benzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)-benzoic acid; LE 135
LE 135 (10 mg) 4-(7,8,9,10-tetrahydro-5,7,7,10,10-pentamethyl-5H-benzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)-benzoic acid; LE 135
LE 135 (5 mg) 4-(7,8,9,10-tetrahydro-5,7,7,10,10-pentamethyl-5H-benzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)-benzoic acid; LE 135
Fluorouracil (10 g) 5-fluoro-2,4(1H,3H)-pyrimidinedione; NSC 19893|Ro 2-9757|U-8953; Fluorouracil
Fluorouracil (25 g) 5-fluoro-2,4(1H,3H)-pyrimidinedione; NSC 19893|Ro 2-9757|U-8953; Fluorouracil
Fluorouracil (5 g) 5-fluoro-2,4(1H,3H)-pyrimidinedione; NSC 19893|Ro 2-9757|U-8953; Fluorouracil
Fluorouracil (50 g) 5-fluoro-2,4(1H,3H)-pyrimidinedione; NSC 19893|Ro 2-9757|U-8953; Fluorouracil
Ampicillin (sodium salt) (100 g) (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3。2。0]heptane-2-carboxylic acid, monosodium salt; Ampicillin (sodium salt)
Ampicillin (sodium salt) (25 g) (2S,5R,6R)-6-[[(2R)-2-amino-2-phenylacetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3。2。0]heptane-2-carboxylic acid, monosodium salt; Ampicillin (sodium salt)